FibroGen, Inc. (FGEN)

R&D Expenses

$6.82M

Quarterly · Period ending: · USD

FGEN logo

FGEN R&D Expenses

Latest reported$6.82M
FGEN Quarterly R&D Expenses ($15.07M → $6.82M)
High-resolution chart · PNG

FGEN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

FibroGen, Inc. R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
6,821,000
7,566,000
7,268,000
1,209,000
5,865,000
9,175,000
1,486,000
21,708,000
32,360,000
36,489,000
51,703,000
61,194,000
95,478,000
74,486,000
61,628,000
75,182,000
70,963,000
89,018,000
113,920,000
75,880,000
122,567,000
74,676,000
78,132,000
58,476,000
61,414,000
54,902,000
56,797,000
49,963,000
52,008,000
50,496,000
70,284,000
56,443,000
52,138,000
56,974,000
52,469,000
50,336,000
46,981,000
46,732,000
50,607,000
40,558,000
52,392,000
43,650,000
59,924,000
52,071,000
51,555,000
50,539,000
51,258,000
40,617,000
33,269,000
25,650,000
29,434,000
23,184,000
18,023,000
15,069,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.